Using a pharmacogenomic algorithm to guide the treatment of depression.

Translational psychiatry

Volumn 2, Issue , 2012, Pages

  Hall Flavin, D K ^a   Winner, J G ^b   Allen, J D ^b   Jordan, J J ^b   Nesheim, R S ^b   Snyder, K A ^b   Drews, M S ^b   Eisterhold, L L ^b   Biernacka, J M ^b   Mrazek, D A ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CYTOCHROME P450; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER;

ADULT; AGED; ALGORITHM; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; EVALUATION; FEMALE; GENETICS; GENOTYPING TECHNIQUE; HUMAN; MAJOR DEPRESSION; MALE; METHODOLOGY; MIDDLE AGED; OUTPATIENT DEPARTMENT; PHARMACOGENETICS; PILOT STUDY; PROSPECTIVE STUDY; PSYCHOLOGICAL RATING SCALE; TREATMENT OUTCOME;

ADULT; AGED; ALGORITHMS; AMBULATORY CARE FACILITIES; ANTIDEPRESSIVE AGENTS; COHORT STUDIES; CYTOCHROME P-450 ENZYME SYSTEM; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENOTYPING TECHNIQUES; HUMANS; MALE; MIDDLE AGED; PHARMACOGENETICS; PILOT PROJECTS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TREATMENT OUTCOME;

EID: 84873966738     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2012.99     Document Type: Article

References (0)